{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:40:22Z","timestamp":1772502022923,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pfizer Pharmaceuticals Korea"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1002-6","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T08:26:49Z","timestamp":1534148809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Safety and efficacy of Rapamune\u00ae (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea"],"prefix":"10.1186","volume":"19","author":[{"given":"Hee Jung","family":"Jeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hahn-Ey","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-7797","authenticated-orcid":false,"given":"Jaeseok","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1097\/01.tp.0000178393.78084.9b","volume":"80","author":"G Russ","year":"2005","unstructured":"Russ G, Segoloni G, Oberbauer R, Legendre C, Mota A, Eris J, et al. Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function. Transplantation. 2005;80:1204\u201311.","journal-title":"Transplantation"},{"key":"1002_CR2","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/j.1600-6143.2011.03637.x","volume":"11","author":"Y Lebranchu","year":"2011","unstructured":"Lebranchu Y, Thierry A, Thervet E, Buchler M, Etienne I, Westeel PF, et al. Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study. Am J Transplant. 2011;11:1665\u201375.","journal-title":"Am J Transplant"},{"key":"1002_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1600-6143.2009.02615.x","volume":"9","author":"Y Lebranchu","year":"2009","unstructured":"Lebranchu Y, Thierry A, Toupance O, Westeel PF, Etienne I, Thervet E, et al. Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study. Am J Transplant. 2009;9:1115\u201323.","journal-title":"Am J Transplant"},{"key":"1002_CR4","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1111\/j.1600-6143.2012.04036.x","volume":"12","author":"Y Lebranchu","year":"2012","unstructured":"Lebranchu Y, Snanoudj R, Toupance O, Weestel PF, Hurault de Ligny B, Buchler M, et al. Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study. Am J Transplant. 2012;12:1801\u201310.","journal-title":"Am J Transplant"},{"key":"1002_CR5","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1681\/ASN.2005050512","volume":"16","author":"C White","year":"2005","unstructured":"White C, Akbari A, Hussain N, Dinh L, Filler G, Lepage N, et al. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol. 2005;16:3763\u201370.","journal-title":"J Am Soc Nephrol"},{"key":"1002_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5414\/CN107662","volume":"79","author":"N Townamchai","year":"2013","unstructured":"Townamchai N, Praditpornsilpa K, Chawatanarat T, Avihingsanon Y, Tiranathanagul K, Katavetin P, et al. The validation of estimated glomerular filtration rate (eGFR) equation for renal transplant recipients. Clin Nephrol. 2013;79:206\u201313.","journal-title":"Clin Nephrol"},{"key":"1002_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/phar.1692","volume":"36","author":"MJ Felix","year":"2016","unstructured":"Felix MJ, Felipe CR, Tedesco-Silva H, Osmar M-PJ. Time-dependent and immunosuppressive drug-associated adverse event profiles in De novo kidney transplant recipients converted from Tacrolimus to Sirolimus regimens. Pharmacotherapy. 2016;36:152\u201365.","journal-title":"Pharmacotherapy"},{"key":"1002_CR8","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1097\/TXD.0000000000000579","volume":"2","author":"H Tedesco-Silva","year":"2016","unstructured":"Tedesco-Silva H, Peddi VR, Sanchez-Fructuoso A, Marder BA, Russ GR, Diekmann F, et al. Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients. Transplant Direct. 2016;2:e69.","journal-title":"Transplant Direct"},{"key":"1002_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMoa1204166","volume":"367","author":"S Euvrard","year":"2012","unstructured":"Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med. 2012;367:329\u201339.","journal-title":"N Engl J Med"},{"key":"1002_CR10","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.transproceed.2010.03.051","volume":"42","author":"M Manuelli","year":"2010","unstructured":"Manuelli M, De Luca L, Iaria G, Tatangelo P, Sforza D, Perrone L, et al. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation. Transplant Proc. 2010;42:1314\u20136.","journal-title":"Transplant Proc"},{"key":"1002_CR11","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.transproceed.2016.08.008","volume":"48","author":"G Laham","year":"2016","unstructured":"Laham G, Scuteri R, Cornicelli P, Arriola M, Raffaele PM, Davalos Michel M, et al. Surveillance registry of Sirolimus use in recipients of kidney allografts from expanded criteria donors. Transplant Proc. 2016;48:2650\u20135.","journal-title":"Transplant Proc"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1002-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1002-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1002-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T19:10:49Z","timestamp":1565637049000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1002-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1002-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"5 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Boards of Kangdong Sacred Heart Hospital, Maryknoll Medical Center, Seoul National University Hospital, Korea University Anam Hospital, Konkuk University Medical Center, Yeungnam University Medical Center, the Catholic University of Korea Seoul St. Mary\u2019s Hospital, Kyungpook National University Hospital, Keimyung University Dongsan Medical Center, Gangnam Severance Hospital, Pusan National University Hospital, Samsung Medical Center, Asan Medical Center, and the Catholic University of Korea Uijeongbu St. Mary\u2019s Hospital. The evidence of a personally signed and dated informed consent document indicating that the subject had been informed of all pertinent aspects of the study. For patients aged less than 19\u00a0years, informed consent was obtained from both patient and parents or guardians.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HJJ and JY have no competing interests. HEL has disclosed that she is an employee of Pfizer Pharmaceuticals Korea Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"201"}}